Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study
2023 · Expert Opinion on Biological Therapy · 8 citations
https://doi.org/10.1080/14712598.2023.2185510
G
Giovanni Cataletti
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
40
Citations
4
h-index
1
i10-index
Giovanni Cataletti is an academic researcher from Luigi Sacco Hospital. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Liver Diseases and Immunity. The author has an h-index of 4, co-authored 15 publications.
Papers by this author
worksLong-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study
2024 · Journal of Clinical Medicine · 8 citations
https://doi.org/10.3390/jcm13237192
Sonographic detection of massive colonic pseudopolyposis in inflammatory bowel diseases
2024 · Journal of Ultrasound · 1 citations
https://doi.org/10.1007/s40477-023-00853-w
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
2024 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.25039971
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat